ClinicalTrials.govpublic full text
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
sickle cell disease, organ damage, hematopoietic cell transplant, haploidentical, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861208
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.